SENS-U: Evaluation of a Wearable Ultrasonic Bladder Sensor for children with clinical incontinence problems compared to treatment as usual (TAU)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00023190

Enrollment

Registered

2020-11-06

Start date

2024-12-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F98.0 N39.48

Interventions

Group 1: Treatment with SENS-U over a period of 3 months Group 2: Treatment as Usual (TaU)

Eligibility

Sex/Gender

All

Age

5 Years to 17 Years

Inclusion criteria

Inclusion criteria: All children with a confirmed diagnosis of monosymptomatic NE or DUI with voiding postponement, that were presented in a tertiary outpatient clinic specialized for incontinence within 24 months.

Exclusion criteria

Exclusion criteria: - age below 5 or >17 years; - diagnosis of fecal incontinence or constipation; - intake of medication for incontinence (e.g. desmopressin, anticholinergics); - intake of medication that may develop incontinence as side effect (e. g. antidepressants, antipsychotic drugs); - children with severe somatic conditions

Design outcomes

Primary

Measure	Time frame
frequency of incontinent episodes before treatment and after 3 months of treatment; treatment success according to ICCS criteria after 3 months of treatment	—

Secondary

Measure	Time frame
teratment satisfaction, usability	—

Countries

Germany

Contacts

Public ContactJustine Hussong

Klinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie

justine.hussong@uks.eu06841 16 24385

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026